FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $174,688 | -58.6% | 17,313 | -8.0% | 0.00% | -50.0% |
| Q3 2022 | $422,000 | -3.2% | 18,828 | +7.1% | 0.00% | 0.0% |
| Q2 2022 | $436,000 | -33.7% | 17,581 | +3.5% | 0.00% | -33.3% |
| Q1 2022 | $658,000 | -36.5% | 16,980 | -4.2% | 0.00% | -25.0% |
| Q4 2021 | $1,037,000 | -0.5% | 17,727 | +0.8% | 0.00% | -20.0% |
| Q3 2021 | $1,042,000 | -31.7% | 17,585 | 0.0% | 0.01% | -28.6% |
| Q2 2021 | $1,526,000 | -4.4% | 17,585 | -9.2% | 0.01% | 0.0% |
| Q1 2021 | $1,597,000 | -43.0% | 19,365 | -37.1% | 0.01% | -41.7% |
| Q4 2020 | $2,800,000 | +130.1% | 30,798 | +1.1% | 0.01% | +100.0% |
| Q3 2020 | $1,217,000 | +21.9% | 30,458 | +4.7% | 0.01% | +20.0% |
| Q2 2020 | $998,000 | +76.3% | 29,083 | +14.1% | 0.01% | +25.0% |
| Q1 2020 | $566,000 | – | 25,492 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,073,190 | $26,599,000 | 26.59% |
| Polaris Venture Management Co. V, L.L.C. | 1,823,186 | $23,391,000 | 24.97% |
| Casdin Capital, LLC | 2,550,000 | $32,717,000 | 5.60% |
| Redmile Group, LLC | 10,359,666 | $132,915,000 | 5.34% |
| Aquilo Capital Management, LLC | 697,096 | $8,944,000 | 4.33% |
| Eversept Partners, LP | 165,000 | $2,116,950 | 1.15% |
| Artal Group S.A. | 2,150,000 | $27,585,000 | 1.02% |
| AlpInvest Partners B.V. | 26,925 | $345,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,654,865 | $21,232,000 | 0.85% |
| Lisanti Capital Growth, LLC | 142,760 | $1,832,000 | 0.74% |